Randomized Controlled Trial
Safety and tolerability of the novel inhaled corticosteroid fluticasone furoate in combination with the β2 agonist vilanterol administered once daily for 52 weeks in patients >=12 years old with asthma: a randomised trial.
Thorax. 2013 Jun 1;68(6):513-20.
Randomized Controlled Trial
Effect of once-daily fluticasone furoate/vilanterol on 24-hour pulmonary function in patients with chronic obstructive pulmonary disease: a randomized, three-way, incomplete block, crossover study.
Clin Ther. 2012 Aug 1;34(8):1655-66.e5.
Randomized Controlled Trial
Once-daily fluticasone furoate alone or combined with vilanterol in persistent asthma.
Eur. Respir. J. 2014 Mar 1;43(3):773-82.